Decision Resources projects more than 150% growth in multiple myeloma market
WALTHAM, Mass. The market for drugs that treat a cancer of the bone marrow will more than double during the 10-year period between 2008 and 2018, according to a new report by market research firm Decision Resources.
According to the report, the multiple myeloma market will have grown from $2.1 billion in 2008 to $5.3 billion by 2018 in the United States, United Kingdom, Germany, France, Spain, Italy and Japan.
Increased use of Celgene’s Revlimid (lenalidomide) and launches of such drugs as Celgene’s pomalidomide and Onyx Pharmaceuticals’ carfilzomib will mostly drive the market growth, according to the report. Revlimid, Velcade (bortezomib), made by Millennium Pharmacueticals and Johnson & Johnson, and Thalomid (thalidomide), made by Celgene and Fujimoto Seiyaku, currently dominate the market.
A&P teams up with Zavers to offer customers mobile coupons
KANSAS CITY, Kan. A&P has joined forces with a digital incentive and information management company to offer customers mobile coupons.
Beginning this month, A&P shoppers can use Zavers’ “text and save” mobile coupon offering through a media platform the company said, “is a unique combination of innovative technology and consumer simplicity.”
“Consumers today want immediate gratification, and with the Zavers mobile platform there is no delay — users can find, save, and redeem coupons at the moment of the truth, instantly in the store. This is a difference-maker for our product advertisers, retailers and shoppers,” said Zavers chief marketing officer Anita Newton.
In addition to A&P, other stores have begun using Zavers’ mobile platform as part of the Red Tag Online Savings program, including Waldbaum’s and SuperFresh, the Online Advantage Program at Pathmark and the Fresh Online Savings program at The Food Emporium.
Garcia reappointed to state pharmacy board
MIAMI EVP pharmacy operations for the largest Hispanic-owned pharmacy chain in the United States was reappointed to the Florida Board of Pharmacy.
Albert Garcia of Navarro Discount Pharmacies will serve a four-year term, Navarro said Friday. Garcia was originially appointed to the Florida Board of Pharmacy — an independent, state health regulatory agency that regulates the practice of pharmacy and protects the health, safety and welfare of the citizens of Florida — in 2004 by former Gov. Jeb Bush.
As EVP pharmacy operations, Garcia oversees several hundred employees and is responsible for the overall operations of Navarro’s 27 pharmacy locations in Miami-Dade County. As a 30-year pharmacy veteran, Garcia also is a member of the Florida Pharmacy Association and the American Pharmaceutical Association.
“Albert Garcia is a third generation pharmacist that has brought a wealth of knowledge to our pharmacy team,” said Steve Kaczynski, Navarro Discount Pharmacies CEO. “As a locally owned-company, we are very proud of his accomplishments and his 33-year successful career in the pharmaceutical industry.”